Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Mar. 31, 2020
Jun. 29, 2020
Document and Entity Information [Abstract]    
Entity Registrant Name Actinium Pharmaceuticals, Inc.  
Entity Central Index Key 0001388320  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Mar. 31, 2020  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Shell Company false  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   395,154,726
Entity File Number 001-36374  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code DE